<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Systems Biology - Latest articles</title>
		<link>http://www.biomedcentral.com/bmcsystbiol/</link>
		<description>The latest articles from BMC Systems Biology (ISSN 1752-0509) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/78"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/77"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/76"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/75"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/74"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/73"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/72"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/71"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/70"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1752-0509/2/69"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/78">
            
            <title>Exact model reduction of combinatorial reaction networks</title>
			<description>Background:
Receptors and scaffold proteins usually possess a high number of distinct binding domains inducing the formation of large multiprotein signaling complexes. Due to combinatorial reasons the number of distinguishable species grows exponentially with the number of binding domains and can easily reach several millions. Even by including only a limited number of components and binding domains the resulting models are very large and hardly manageable. A novel model reduction technique allows the significant reduction and modularization of these models.
Results:
We introduce methods that extend and complete the already introduced approach. For instance, we provide techniques to handle the formation of multi-scaffold complexes as well as receptor dimerization. Furthermore, we discuss a new modeling approach that allows the direct generation of exactly reduced model structures. The developed methods are used to reduce a model of EGF and insulin receptor crosstalk comprising 5,182 ordinary differential equations (ODEs) to a model with 87 ODEs.
Conclusions:
The methods, presented in this contribution, significantly enhance the available methods to exactly reduce models of combinatorial reaction networks.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/78</link>
			
			 	<dc:creator>Holger Conzelmann, Dirk Fey and Ernst D Gilles</dc:creator>
			
			<dc:source>BMC Systems Biology 2008, 2:78</dc:source>
			<dc:date>2008-08-28</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-78</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>78</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-28</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/77">
            
            <title>A compartment model of VEGF distribution in blood, healthy and diseased tissues</title>
			<description>Background:
Angiogenesis is a process by which new capillaries are formed from pre-existing blood vessels in physiological (e.g., exercise, wound healing) or pathological (e.g., ischemic limb as in peripheral arterial disease, cancer) contexts. This neovascular mechanism is mediated by the vascular endothelial growth factor (VEGF) family of cytokines. Although VEGF is often targeted in anti-angiogenic therapies, there is little knowledge about how its concentration may vary between tissues and the vascular system. A compartment model is constructed to study the VEGF distribution in the tissue (including matrix-bound, cell surface receptor-bound and free VEGF isoforms) and in the blood. We analyze the sensitivity of this distribution to the secretion rate, clearance rate and vascular permeability of VEGF. 
Results:
We find that, in a physiological context, VEGF concentration varies approximately linearly with the VEGF secretion rate. VEGF concentration in blood but not in tissue is dependent on the vascular permeability of healthy tissue. Model simulations suggest that relative VEGF increases are similar in blood and tissue during exercise and return to baseline within several hours. In a pathological context (tumor), we find that blood VEGF concentration is relatively insensitive to increased vascular permeability in tumors, to the secretion rate of VEGF by tumors and to the clearance. However, it is sensitive to the vascular permeability in the healthy tissue. Finally, the VEGF distribution profile in healthy tissue reveals that about half of the VEGF is complexed with the receptor tyrosine kinase VEGFR2 and the co-receptor Neuropilin-1. In diseased tissues, this binding can be reduced to 15% while VEGF bound to the extracellular matrix and basement membranes increases.
Conclusions:
The results are of importance for physiological conditions (e.g., exercise) and pathological conditions (e.g., peripheral arterial disease, coronary artery disease, cancer). This mathematical model can serve as a tool for understanding the VEGF distribution in physiological and pathological contexts as well as a foundation to investigate pro- or anti-angiogenic strategies.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/77</link>
			
			 	<dc:creator>Marianne O Stefanini, Florence TH Wu, Feilim Mac Gabhann and Aleksander S Popel</dc:creator>
			
			<dc:source>BMC Systems Biology 2008, 2:77</dc:source>
			<dc:date>2008-08-19</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-77</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>77</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-19</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/76">
            
            <title>Rapidly exploring structural and dynamic properties of signaling networks using PathwayOracle</title>
			<description>Background:
In systems biology the experimentalist is presented with a selection of software for analyzing dynamic properties of signaling networks. These tools either assume that the network is in steady-state or require highly parameterized models of the network of interest. For biologists interested in assessing how signal propagates through a network under specific conditions, the first class of methods does not provide sufficiently detailed results and the second class requires models which may not be easily and accurately constructed. A tool that is able to characterize the dynamics of a signaling network using an unparameterized model of the network would allow biologists to quickly obtain insights into a signaling network's behavior.
Results:
We introduce PathwayOracle, an integrated suite of software tools for computationally inferring and analyzing structural and dynamic properties of a signaling network. The feature which differentiates PathwayOracle from other tools is a method that can predict the response of a signaling network to various experimental conditions and stimuli using only the connectivity of the signaling network. Thus signaling models are relatively easy to build. The method allows for tracking signal flow in a network and comparison of signal flows under different experimental conditions. In addition, PathwayOracle includes tools for the enumeration and visualization of coherent and incoherent signaling paths between proteins, and for experimental analysis &#8211; loading and superimposing experimental data, such as microarray intensities, on the network model.
Conclusion:
PathwayOracle provides an integrated environment in which both structural and dynamic analysis of a signaling network can be quickly conducted and visualized along side experimental results. By using the signaling network connectivity, analyses and predictions can be performed quickly using relatively easily constructed signaling network models. The application has been developed in Python and is designed to be easily extensible by groups interested in adding new or extending existing features. PathwayOracle is freely available for download and use.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/76</link>
			
			 	<dc:creator>Derek Ruths, Luay Nakhleh and Prahlad T Ram</dc:creator>
			
			<dc:source>BMC Systems Biology 2008, 2:76</dc:source>
			<dc:date>2008-08-19</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-76</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>76</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-19</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/75">
            
            <title>Explaining oscillations and variability in the p53-Mdm2 system </title>
			<description>Background:
In individual living cells p53 has been found to be expressed in a series of discrete pulses after DNA damage. Its negative regulator Mdm2 also demonstrates oscillatory behaviour. Attempts have been made recently to explain this behaviour by mathematical models but these have not addressed explicit molecular mechanisms. We describe two stochastic mechanistic models of the p53/Mdm2 circuit and show that sustained oscillations result directly from the key biological features, without assuming complicated mathematical functions or requiring more than one feedback loop. Each model examines a different mechanism for providing a negative feedback loop which results in p53 activation after DNA damage. The first model (ARF model) looks at the mechanism of p14ARF which sequesters Mdm2 and leads to stabilisation of p53. The second model (ATM model) examines the mechanism of ATM activation which leads to phosphorylation of both p53 and Mdm2 and increased degradation of Mdm2, which again results in p53 stabilisation. The models can readily be modified as further information becomes available, and linked to other models of cellular ageing. 
Results:
The ARF model is robust to changes in its parameters and predicts undamped oscillations after DNA damage so long as the signal persists. It also predicts that if there is a gradual accumulation of DNA damage, such as may occur in ageing, oscillations break out once a threshold level of damage is acquired. The ATM model requires an additional step for p53 synthesis for sustained oscillations to develop. The ATM model shows much more variability in the oscillatory behaviour and this variability is observed over a wide range of parameter values. This may account for the large variability seen in the experimental data which so far has examined ARF negative cells. 
Conclusions:
The models predict more regular oscillations if ARF is present and suggest the need for further experiments in ARF positive cells to test these predictions. Our work illustrates the importance of systems biology approaches to understanding the complex role of p53 in both ageing and cancer. </description>
			<link>http://www.biomedcentral.com/1752-0509/2/75</link>
			
			 	<dc:creator>Carole J Proctor and Douglas A Gray</dc:creator>
			
			<dc:source>BMC Systems Biology 2008, 2:75</dc:source>
			<dc:date>2008-08-18</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-75</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>75</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-18</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/74">
            
            <title>A review of imaging techniques for systems biology</title>
			<description>This paper presents a review of imaging techniques and of their utility in system biology. During the last decade systems biology has matured into a distinct field and imaging has been increasingly used to enable the interplay of experimental and theoretical biology. In this review, we describe and compare the roles of microscopy, ultrasound, CT (Computed Tomography), MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), and molecular probes such as quantum dots and nanoshells in systems biology. As a unified application area among these different imaging techniques, examples in cancer targeting are highlighted.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/74</link>
			
			 	<dc:creator>Armen R Kherlopian, Ting Song, Qi Duan, Mathew A Neimark, Ming J Po, John K Gohagan and Andrew F Laine</dc:creator>
			
			<dc:source>BMC Systems Biology 2008, 2:74</dc:source>
			<dc:date>2008-08-12</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-74</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>74</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/73">
            
            <title>On the origin of distribution patterns of motifs in biological
networks.</title>
			<description>Background:
Inventories of small subgraphs in biological networks have identified commonly-recurring patterns, called motifs. The inference that these motifs have been selected for function rests on the idea that their occurrences are significantly more frequent than random.  
Results:
Our analysis of several large biological networks suggests, in contrast, that the frequencies of appearance of common subgraphs are similar in natural and corresponding random networks. 
Conclusions:
Indeed, certain topological features of biological networks give rise naturally to the common appearance of the motifs. We therefore question whether frequencies of occurrences are reasonable evidence that the structures of motifs have been selected for their functional contribution to the operation of networks.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/73</link>
			
			 	<dc:creator>Arun S. Konagurthu and Arthur M. Lesk</dc:creator>
			
			<dc:source>BMC Systems Biology 2008, 2:73</dc:source>
			<dc:date>2008-08-12</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-73</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>73</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/72">
            
            <title>Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements</title>
			<description>Background:
With the advance of large-scale omics technologies, it is now feasible to reversely engineer the underlying genetic networks that describe the complex interplays of molecular elements that lead to complex diseases. Current networking approaches are mainly focusing on building genetic networks at large without probing the interaction mechanisms specific to a physiological or disease condition. The aim of this study was thus to develop such a novel networking approach based on the relevance concept, which is ideal to reveal integrative effects of multiple genes in the underlying genetic circuit for complex diseases.
Results:
The approach started with identification of multiple disease pathways, called a gene forest, in which the genes extracted from the decision forest constructed by supervised learning of the genome-wide transcriptional profiles for patients and normal samples. Based on the newly identified disease mechanisms, a novel pair-wise relevance metric, adjusted frequency value, was used to define the degree of genetic relationship between two molecular determinants. We applied the proposed method to analyze a publicly available microarray dataset for colon cancer. The results demonstrated that the colon cancer-specific gene network captured the most important genetic interactions in several cellular processes, such as proliferation, apoptosis, differentiation, mitogenesis and immunity, which are known to be pivotal for tumourigenesis. Further analysis of the topological architecture of the network identified three known hub cancer genes [interleukin 8 (IL8) (p=0), desmin (DES) (p=2.71x10-6) and enolase 1 (ENO1) (p=4.19x10-5)], while two novel hub genes [RNA binding motif protein 9 (RBM9) (p=1.50x10-4) and ribosomal protein L30 (RPL30) (p=1.50x10-4)] may define new central elements in the gene network specific to colon cancer. Gene Ontology (GO) based analysis of the colon cancer-specific gene network and the sub-network that consisted of three-way gene interactions suggested that tumourigenesis in colon cancer resulted from dysfunction in protein biosynthesis and categories associated with ribonucleoprotein complex which are well supported by multiple lines of experimental evidence.
Conclusions:
This study demonstrated that IL8, DES and ENO1 act as the central elements in colon cancer susceptibility, and protein biosynthesis and the ribosome-associated function categories largely account for the colon cancer tumuorigenesis. Thus, the newly developed relevancy-based networking approach offers a powerful means to reverse-engineer the disease-specific network, a promising tool for systematic dissection of complex diseases.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/72</link>
			
			 	<dc:creator>Wei Jiang, Xia Li, Shaoqi Rao, Lihong Wang, Lei Du, Chuanxing Li, Chao Wu, Hongzhi Wang, Yadong Wang and Baofeng Yang</dc:creator>
			
			<dc:source>BMC Systems Biology 2008, 2:72</dc:source>
			<dc:date>2008-08-10</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-72</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>72</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/71">
            
            <title>The genome-scale metabolic model iIN800 of Saccharomyces cerevisiae and its validation: a scaffold to query lipid metabolism </title>
			<description>Background:
Up to now, there have been three versions of a yeast genome-scale metabolic model: iFF708, iND750 and iLL672.  All three models, however, lack a detailed description of lipid metabolism and thus are unable to be used as integrated scaffolds for gaining insights into lipid metabolism from multilevel omic measurement technologies (e.g. genome-wide mRNA levels). To overcome this limitation, we reconstructed a new version of the Saccharomyces cerevisiae genome-scale model, iIN800, that includes a more rigorous and detailed description of lipid metabolism.
Results:
The reconstructed metabolic model comprises 1446 reactions and 1013 metabolites.  Beyond incorporating new reactions involved in lipid metabolism, we also present new biomass equations that improve the predictive power of flux balance analysis simulations.  Predictions of both growth capability and large scale in silico single gene deletions by iIN800 were consistent with experimental data.  In addition, 13C-labeling experiments validated the new biomass equations and calculated intracellular fluxes.  To demonstrate the applicability of iIN800, we show that the model can be used as a scaffold to reveal the regulatory importance of lipid metabolism precursors and intermediates that would have been missed in previous models from transcriptome datasets. 
Conclusions:
We anticipate that performing integrated analyses using iIN800 as a network scaffold will be a valuable tool for elucidating the behavior of complex metabolic networks, particularly for identifying regulatory targets in lipid metabolism that can be used for industrial applications or for understanding lipid disease states.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/71</link>
			
			 	<dc:creator>Intawat Nookaew, Michael C Jewett, Asawin Meechai, Chinae Thammarongtham, Kobkul Laoteng, Supapon Cheevadhanarak, Jens Nielsen and Sakarindr Bhumiratana</dc:creator>
			
			<dc:source>BMC Systems Biology 2008, 2:71</dc:source>
			<dc:date>2008-08-07</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-71</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>71</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-07</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/70">
            
            <title>An enzyme-centric approach for modelling non-linear biological complexity</title>
			<description>Background:
The current challenge of Systems Biology is to integrate high throughput data sets for simulating the complexity of biological networks, exploit the evolution of nature-designed networks that maintain the robustness of a biological system, and thereby generate novel, experimentally testable hypotheses. In order to simulate non-linear biological complexities, we have previously developed an Enzyme-Centric mechanistic modeling approach and validated it using metabolic network in E. coli. The idea is to use prior knowledge of catalytic and regulatory mechanisms of each enzyme within the metabolic network to build a dynamic model for investigating the network level regulation and thus understand the nature design principle behind the network.
Results:
In this paper, we further demonstrate the application of complex enzyme catalytic and regulatory modules to simulate nonlinear network regulatory patterns vs. simple linear conversion model. We learned and validated that it is essential to incorporate prior knowledge from the literature to simulate non-linear biological complexities. The network expandability is demonstrated and validated with the complex amino acid biosynthetic network with multi-regulations. Also, we demonstrated the compatibility of mechanistic models within close species. Furthermore, the eukaryotic protein factory model for insuring steady mRNA production is simulated and the coupling of RNA transcription and splicing is validated by both mathematical simulation and experimental analysis. 
Conclusions:
We demonstrated the importance of modeling complex enzyme catalytic and regulatory mechanisms to further understand nonlinear network regulatory patterns. The simulations presented in this paper reveal how a living system maintains homeostasis and its robustness to continue functioning while facing environmental stresses or genetic mutations.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/70</link>
			
			 	<dc:creator>Chin-Rang Yang</dc:creator>
			
			<dc:source>BMC Systems Biology 2008, 2:70</dc:source>
			<dc:date>2008-08-01</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-70</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>70</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1752-0509/2/69">
            
            <title>Structural similarity of genetically interacting proteins</title>
			<description>Background:
The study of gene mutants and their interactions is fundamental to understanding gene function and backup mechanisms within the cell. The recent availability of large scale genetic interaction networks in yeast and worm allows the investigation of the biological mechanisms underlying these interactions at a global scale. To date, less than 2% of the known genetic interactions in yeast or worm can be accounted for by sequence similarity.
Results:
Here, we perform a genome-scale structural comparison among protein pairs in the two species. We show that significant fractions of genetic interactions involve structurally similar proteins, spanning 7&#8211;10% and 14% of all known interactions in yeast and worm, respectively. We identify several structural features that are predictive of genetic interactions and show their superiority over sequence-based features.
Conclusion:
Structural similarity is an important property that can explain and predict genetic interactions. According to the available data, the most abundant mechanism for genetic interactions among structurally similar proteins is a common interacting partner shared by two genetically interacting proteins.</description>
			<link>http://www.biomedcentral.com/1752-0509/2/69</link>
			
			 	<dc:creator>Oranit Dror, Dina Schneidman-Duhovny, Alexandra Shulman-Peleg, Ruth Nussinov, Haim J Wolfson and Roded Sharan</dc:creator>
			
			<dc:source>BMC Systems Biology 2008, 2:69</dc:source>
			<dc:date>2008-07-31</dc:date>
			<dc:identifier>doi:10.1186/1752-0509-2-69</dc:identifier>
			
			
							
					<prism:publicationName>BMC Systems Biology</prism:publicationName>
					
			
							
					<prism:issn>1752-0509</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>69</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-31</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
